<DOC>
	<DOCNO>NCT01351012</DOCNO>
	<brief_summary>The purpose study examine consumption different dietary oil variety affect broad range metabolic response important development cardiovascular disease . This study examine relationship dietary oil consumption arterial function , blood fat content , blood marker cardiovascular disease risk . Additionally , efficiency body convert fat dietary oil specific fat compound know health benefit examine . Also , correlation psychosocial parameter vascular function study .</brief_summary>
	<brief_title>Canola Oil Multicentre Intervention Trial</brief_title>
	<detailed_description>Although consumption omega-3 fatty acid favorably modulate circulate lipid arterial health , confusion surround specific health benefit plant base alpha-linolenic acid ( ALA ) versus marine derive eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) . This research examine health benefit ALA consumption diet rich canola oil , novel monounsaturated fatty acid ( MUFA ) DHA enrich canola oil , flax oil compare control diet representative North American diet rich omega-6 saturate fat . Treatment oil examine potential influence endothelial dysfunction , inflammation , oxidation , body composition , plasma lipoprotein characterization . Furthermore , effort elucidate genetic factor promote ALA conversion EPA/DHA strengthen role ALA cardiovascular health , major objective correlate common genetic variant fatty acid desaturase 1 ( FADS1 ) fatty acid desaturase 2 ( FADS2 ) gene cluster ALA conversion EPA/DHA n-3 fatty acid composition serum phospholipid response consumption treatment oil . Besides , psychosocial predictor vascular function investigate .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Waist circumference ≥94 cm ( male ) ≥80 cm ( female ) plus least one following : Triglycerides ≥1.7 mmol/L High density lipoprotein ( HDL ) cholesterol &lt; 1 mmol/L ( male ) &lt; 1.3 mmol/L ( female ) Low density lipoprotein ( LDL ) cholesterol ≥3.5 mmol/L Blood pressure ≥130 mmHg ( systolic ) and/or ≥85 mmHg ( diastolic ) Glucose ≥5.5 mmol/L Thyroid disease Diabetes mellitus Kidney disease Liver disease Smoking Heavy drinking Use medication know affect lipid metabolism last 3 month ( cholestyramine , colestipol , niacin , clofibrate , gemfibrozil , probucol , HMG CoA reductase inhibitor )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Canola oil</keyword>
	<keyword>High oleic canola oil</keyword>
	<keyword>Flax oil</keyword>
	<keyword>ALA</keyword>
	<keyword>DHA</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>FADS1</keyword>
	<keyword>Gut microbiome</keyword>
	<keyword>Body composition</keyword>
	<keyword>Psychosocial status</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Lipids</keyword>
	<keyword>Lipoproteins</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Lipid peroxidation</keyword>
</DOC>